{
    "body": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24565614", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20922352"
    ], 
    "ideal_answer": [
        "Icatibant and ecallantide are medication acting via bradykinin system that are used for treatment of ACE-inhibitor-induced angioedema."
    ], 
    "exact_answer": [
        [
            "icatibant"
        ], 
        [
            "ecallantide"
        ]
    ], 
    "type": "list", 
    "id": "54cf6d40f693c3b16b00000e", 
    "snippets": [
        {
            "offsetInBeginSection": 983, 
            "offsetInEndSection": 1206, 
            "text": "Medications recently developed, primarily icatibant and ecallantide, to control hereditary angioedema, a disorder also associated with kallikrein-kinin activation, have been used to treat ACEI angioedema with some success. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24565614", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 359, 
            "offsetInEndSection": 539, 
            "text": "A patient with acute ACE inhibitor-induced angioedema was treated with icatibant, a specific bradykinin B2 receptor antagonist approved for the treatment of hereditary angioedema. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20922352", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 359, 
            "offsetInEndSection": 538, 
            "text": "A patient with acute ACE inhibitor-induced angioedema was treated with icatibant, a specific bradykinin B2 receptor antagonist approved for the treatment of hereditary angioedema.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20922352", 
            "endSection": "abstract"
        }
    ]
}